Introduction {#sec1}
============

In the adult hematopoietic system, short-lived mature cells are constantly lost and need to be replaced in order to maintain blood homeostasis ([@bib32; @bib57]). This essential task is fulfilled by hematopoietic stem cells (HSCs), which reside in the trabecular areas of the bone marrow ([@bib38; @bib50; @bib61]). HSCs possess the highest self-renewal capacity and produce multipotent progenitors (MPPs) with steadily decreasing self-renewal activity ([@bib52; @bib57]). HSCs and MPPs (HSPC) are contained within a compartment immunophenotypically defined as negative for mature blood cell markers (Lin^−^) and positive for stem cell markers SCA-1 and c-KIT (LS^+^K; [@bib57]). HSPCs eventually commit to more mature lymphoid or myeloid progenitors with increasingly restricted self-renewal and differentiation potential ([@bib15]). The myeloid committed progenitor subset (Lin^−^, SCA-1^−^ and c-KIT^+^; \[LS^−^K\]) comprises common myeloid progenitors (CMPs) as well as more specialized granulocyte-macrophage progenitors (GMPs) and megakaryocyte-erythroid progenitors (MEPs) ([@bib2; @bib37]), which differentiate toward mature effector cells.

Two crucial aspects of early hematopoiesis are multipotency and lineage commitment ([@bib15; @bib52]). Expression profiling of HSPCs by cDNA microarrays has elucidated important aspects of hematopoietic stem cell biology, including the relevance of the KIT^−^ and Wnt^−^ signaling pathways ([@bib13; @bib23; @bib27; @bib42]) for multipotency. Transcriptional control networks active in early hematopoiesis have been studied using single-gene expression analysis ([@bib31]), but their impact on protein levels and posttranscriptional gene expression regulation in HSPCs has not been described.

Recently, transcriptome profiling by next-generation sequencing (NGS; e.g., RNA sequencing \[RNA-seq\]) has significantly extended the possibilities to study gene expression ([@bib34]), which was also used to investigate young versus aged HSCs ([@bib46]). It permits not only the analysis of differential mRNA expression of low abundant regulatory factors, but also the detection of alternative splicing events that can generate different protein isoforms and the identification of noncoding RNAs. Long noncoding RNAs (lncRNAs) ([@bib29]) are involved in the regulation of gene expression at various levels ([@bib36; @bib62]) and can function as oncogenes or tumor-suppressor genes ([@bib16]). Although efforts have been made to identify and elucidate the roles of lncRNAs in stem cells ([@bib39; @bib53]), little is known about the expression of lncRNAs or their functions in hematopoietic stem/progenitors ([@bib35]). Further, the advent of improved proteome techniques has enabled in-depth comparative analysis of RNA and protein signatures in diverse systems ([@bib9; @bib41; @bib55]). Although attempts were made to correlate transcriptome and proteome signatures of hematopoietic immature cells ([@bib45]), a comprehensive comparison is still lacking.

We performed a genome-wide RNA-seq analysis of primary multipotent and self-renewing hematopoietic stem/progenitors and myeloid committed precursors. We report robust and reproducible transcriptome data with more than 19,000 quantified genes including more than 1,300 noncoding RNA species. To address how gene expression is regulated in multipotency and commitment, we integrated our RNA-seq data with the recently reported proteome data set of the identical cell populations ([@bib24]). These data sets outline the dynamic expression changes that occur during the transition of stem/progenitors toward myeloid commitment.

Results {#sec2}
=======

Quantitative Transcriptomic Analysis of Hematopoietic Stem and Progenitor Cells {#sec2.1}
-------------------------------------------------------------------------------

Whole-transcriptome analysis was performed to investigate differences in the gene expression profiles between multipotent hematopoietic stem progenitor cells (HSPCs; LS^+^K) and myeloid committed cells (LS^−^K) of the mouse bone marrow ([Figure 1](#fig1){ref-type="fig"}A). We fluorescence-activated cell sorting (FACS)-sorted 50,000 primary cells of each population in three independent biological experiments ([Figure 1](#fig1){ref-type="fig"}B and [Figure S1](#app2){ref-type="sec"} available online) and enriched for polyadenylated RNA. We generated paired-end libraries and sequenced more than 2 × 10^8^ reads per sample ([Figures S1](#app2){ref-type="sec"} and [S2](#app2){ref-type="sec"}). Quality-control metrics indicated that the data were reproducible and of high quality ([Figures 1](#fig1){ref-type="fig"}C, [S1](#app2){ref-type="sec"}, and [S2](#app2){ref-type="sec"}). We identified the expression of 19,824 genes ([Table S1](#mmc2){ref-type="supplementary-material"}). We classified the quantified genes by RNA categories. As expected after poly(A)-RNA enrichment, the majority of transcripts were categorized as protein-coding genes (78%; 15,474; [Figure 1](#fig1){ref-type="fig"}D). In addition, we classified hits to 23 other noncoding RNA categories including pseudogenes (1,783) and lncRNAs (498).

Differential Gene Expression Analysis Reveals Significant Transcriptional Divergence between HSPCs and Myeloid Committed Precursors {#sec2.2}
-----------------------------------------------------------------------------------------------------------------------------------

We found 3,236 genes to be differentially expressed (false discovery rate \[FDR\] = 0.05) between multipotent and myeloid committed cells, which indicated a high divergence in transcript levels ([Figure 1](#fig1){ref-type="fig"}E; [Table S1](#mmc2){ref-type="supplementary-material"}). Of these, 1,970 genes were highly expressed in HSPCs and 1,266 were higher in LS^−^K cells. As expected, transcripts encoding SCA-1, which was used to sort this population, as well as FLT3 and THY1 surface markers ([@bib1; @bib57]) were preferentially expressed in LS^+^K cells ([Table S1](#mmc2){ref-type="supplementary-material"}). In contrast, neutrophil serine proteases *Ctsg* and *Elane* were highly expressed in LS^−^K cells ([@bib25]). We validated 24 differentially expressed genes by quantitative real-time PCR, which confirmed the robustness of the data for a wide range of gene expression transcript abundances (from 2 to 2,314,409 of the mean of sequenced fragments; [Figure S2](#app2){ref-type="sec"}D).

To investigate the biological roles of our set of differentially expressed genes, we applied a gene ontology (GO) enrichment analysis, using a stratified approach that controls for expression strength biases ([Figure 1](#fig1){ref-type="fig"}F; [Table S2](#mmc3){ref-type="supplementary-material"}). The GO terms overrepresented in LS^+^K cells fell into three main categories: immune response (^∗^ in [Figure 1](#fig1){ref-type="fig"}F; e.g., antigen processing and presentation, inflammatory response), cell adhesion (^∗∗^; chemotaxis), and transcriptional control (^∗∗∗^; negative regulation of transcription). In contrast, metabolism (^∗∗∗∗^; cell redox homeostasis, glycolysis) was significantly overrepresented in myeloid committed cells. Cell cycle (^∗∗∗∗∗^) showed a dual pattern with e.g., negative regulation of cell cycle enriched in LS^+^K and spindle assembly involved in mitosis enriched in myeloid cells, reflecting the higher proliferative state in the committed progenitors. We determined genes that were uniquely detected in HSPCs but not in LS^−^K and vice versa ([Figure S3](#app2){ref-type="sec"}). Although four genes were exclusively detected in LS^−^K myeloid progenitors (*Ivl*, *Gm14705*, *Gp6*, *Zfp819*), 69 genes of diverse RNA categories were only detected in LS^+^K cells and categorized primarily to cell adhesion and immune system process (e.g., Kallikrein-related peptidases *Klk1*, *Klk9*, and *Klk10*; [Figure S3](#app2){ref-type="sec"}), suggesting particular importance of these processes for the HSPC state. In conclusion, the differential expression pattern for key cellular processes demonstrates a distinct transcriptomic composition of multipotent and myeloid committed cells.

Cell-Cycle Activity Is Tightly Regulated in HSPCs and upon Myeloid Commitment {#sec2.3}
-----------------------------------------------------------------------------

Next, we analyzed the protein-protein interaction network of the differentially expressed genes related to cell cycle ([Figure 2](#fig2){ref-type="fig"}A; ^∗∗∗∗∗^ in [Figure 1](#fig1){ref-type="fig"}F). We found negative regulators of mitosis to be highly expressed in LS^+^K cells (*Cdkn1b/p27*), in line with previous work demonstrating regulation of cell-cycle activity in HSPCs ([@bib67; @bib49]). In contrast, a highly interconnected group of proliferation-related genes were enriched in LS^−^K (*Plk1*, *Rps6ka2*). We validated these findings by real-time PCR and extended this expression analysis to more refined myeloid committed progenitors (CMP, MEP, GMP; [Figures 2](#fig2){ref-type="fig"}B, [S4](#app2){ref-type="sec"}A, and S4B). Interestingly, MEPs and GMPs showed higher expression of cell-cycle activators but lower expression of inhibitors compared to HSPCs and CMPs. To test whether these gene expression patterns were reflected functionally, we assessed cell-cycle stages by flow cytometry ([Figures 2](#fig2){ref-type="fig"}C and 2D). In line, HSPCs showed significantly more cells in G0 (36%) compared to overall myeloid committed precursors (17%). Within the LS^−^K compartment, CMPs were cycling less (23%; G0) compared to the more committed MEP (13%) and GMP (11%) populations. Together, these results suggest that the low cell-cycle activity in HSPCs becomes stepwise activated upon myeloid commitment.

Global Analysis of Genes Involved in Transcriptional Control of Multipotency and Commitment {#sec2.4}
-------------------------------------------------------------------------------------------

Next, we investigated the differentially expressed genes related to transcriptional control (^∗∗∗^ in [Figure 1](#fig1){ref-type="fig"}F). Notably, the majority of these were enriched in HSPCs ([Figure 3](#fig3){ref-type="fig"}; 146 out of 177; 82%) and only few in myeloid progenitors (31 out of 177). Classification of these 177 genes according to their molecular function ([Figure 3](#fig3){ref-type="fig"}A; [Table S3](#mmc4){ref-type="supplementary-material"}) revealed various functional categories including ligand-receptors (31) and transcription factors (TFs; 62) ([Figure 3](#fig3){ref-type="fig"}A). We then assigned these differential regulators to signaling pathways ([Table S3](#mmc4){ref-type="supplementary-material"}). We found the expression of the Bmp-Smad-TGF-beta^−^ (*Bmp4*, *Smad1*; [@bib8]) and Wnt^−^Notch^−^ (*Wnt10b*, *Jag2*; [@bib7; @bib27]) signaling pathways to be highly enriched in HSPCs. Notably, six members of the Forkhead box protein family (e.g., *Foxa3*, *Foxr1*) were enriched in HSPCs (2- to 32-fold), whereas *Foxh1* was lowly expressed (−8-fold). Next, we screened the expression of TF targets of Fox family members ([Figure S4](#app2){ref-type="sec"}C). This analysis revealed genes possibly activated downstream of *Foxo1* (*Ccng2*, *Trib3*) in LS^+^K and *Foxh1* (*Aldh1a1*, *Mixl1*) in LS^−^K cells; it also highlights factors potentially repressed by *Foxh1* upon myeloid commitment (*Aldh1a2*, *Pitx2*).

Next, we investigated the expression of long noncoding RNAs (lncRNAs) in LS^+^K and LS^−^K cells ([Figures 3](#fig3){ref-type="fig"}B--3F). From the 489 ENSEMBL-annotated lncRNAs for which we identified expression in our data, 67 were differentially expressed between HSPCs and LS^−^K (FDR = 0.05; 55 up/ 12 down; [Table S1](#mmc2){ref-type="supplementary-material"}). Strikingly, only two out of the 67 differentially expressed lncRNA set were functionally annotated (*H19*, *Meg3*; ([@bib54; @bib63; @bib66])). In contrast, other lncRNAs were also exclusive or strongly differentially expressed in HSPCs (*A930001C03Rik*, *Gm12066*) or LS^−^Ks (*Gm12708*), but they lacked characterization. One of the most abundant lncRNA was *Malat1* (\>800,000 counts in LS^−^K cells; [Figure 3](#fig3){ref-type="fig"}C; [Table S1](#mmc2){ref-type="supplementary-material"}), which showed more than 2-fold higher expression in HSPCs. Increased expression of *Meg3* and *Malat1* in HSPCs was confirmed by independent real-time PCR ([Figure 3](#fig3){ref-type="fig"}D). In order to examine the expression of *Malat1* within the LS^+^K compartment, we performed real-time PCR in refined HSC and MPP populations ([@bib60]). We found *Malat1* to be highly expressed in the most immature HSCs and MPP1 cells compared to later MPPs and LS^−^Ks ([Figure 3](#fig3){ref-type="fig"}E). On the contrary, the high expression of *1700006J14Rik* in LS^−^K was mostly due to its increased expression in MEPs, as shown by real-time PCR ([Figure 3](#fig3){ref-type="fig"}F). In addition to ENSEMBL-annotated lncRNAs, we predicted de novo transcripts using Cufflinks ([@bib51]). In order to increase the confidence of the assemblies, we considered only multiexonic assemblies and we filtered these assemblies based on (1) their length (\>200 bp), (2) proximity to annotated genes (\>10 Mb), (3) coverage (\>20 mean fragment counts across all the samples), and (4) lack of coding sequences (\<100 consecutive codons). After these filters, we predicted 713 potential de novo lncRNAs, of which 149 were differentially expressed (FDR = 0.1; [Table S4](#mmc5){ref-type="supplementary-material"}). This set represents a predictive starting point for further validation. Taken together, we provide a comprehensive expression landscape of transcriptional control factors and lncRNAs, which serves as a resource to investigate regulatory circuits controlling early adult hematopoiesis.

Regulation of Gene Expression in HSPCs and Myeloid Precursors {#sec2.5}
-------------------------------------------------------------

Next, we tested for differential usage of exons between LS^+^K and LS^−^K cells using DEXseq ([Figures 4](#fig4){ref-type="fig"}A and 4B; [@bib4]). In total, 4,096 genes showed evidence of differential exon usage (<http://www-huber.embl.de/DEULSK/testForDEU.html>), out of which 755 were differentially expressed genes. Because we identified a transcriptional control cluster ([Table S3](#mmc4){ref-type="supplementary-material"}) to be enriched in HSPCs, we further investigated exon usage differences within this regulatory network. We found 48 out of 177 genes showing differential exon usage ([Figure 4](#fig4){ref-type="fig"}A). Of these, we exemplify the MyoD family inhibitor, *Mdfi*, a regulator of Wnt signaling ([@bib26]). Its fifth exon was almost exclusively expressed in HSPCs, suggesting specific roles for different *Mdfi* isoforms in stem/progenitors ([Figure 4](#fig4){ref-type="fig"}B). Complementarily, we used MISO ([@bib22]) to quantify annotated alternative splicing events and used DEXSeq to test for differences in these annotated splicing events between the LS^+^K and LS^−^K populations. Using this approach, we found 214 differentially spliced events (FDR = 0.1; [Table S5](#mmc6){ref-type="supplementary-material"}). These findings suggest transcript isoform regulation as an unexpectedly abundant regulatory mechanism at the transition from HSPCs to LS^−^K.

In order to explore potential posttranscriptional regulation, we integrated these RNA-seq data with our previously reported proteome data set generated from the identical cell populations ([@bib24]) ([Figures 4](#fig4){ref-type="fig"}C--4F; [Table S6](#mmc7){ref-type="supplementary-material"}). Ninety-eight percent of all quantified proteins were assigned to the respective gene identifier (4,919 out of 5,027; [Figure 4](#fig4){ref-type="fig"}C). Of these, 419 were found to be differentially expressed both at the RNA and protein level (FDR = 0.1). Overall, the correlation coefficient of the RNA and protein fold changes was 0.39 ([Figure 4](#fig4){ref-type="fig"}D). However, when we restricted the genes to those detected as differentially expressed on RNA and protein levels, the correlation coefficient increased substantially (R = 0.81; [Figure 4](#fig4){ref-type="fig"}D). We found 82% of the differentially expressed genes with consistent sign of fold changes in mRNA and protein levels ([Figure 4](#fig4){ref-type="fig"}E, 342 out of 419). In contrast, a group of 77 hits showed anticorrelation in their fold changes, with increased protein but decreased transcript levels in HSPCs compared to LS^−^Ks ([Figure 4](#fig4){ref-type="fig"}E; [Table 1](#tbl1){ref-type="table"}). These anticorrelated genes were enriched for metabolic process and response to oxidative stress suggesting the involvement of posttranscriptional mechanisms in the regulation of these processes ([Figure 4](#fig4){ref-type="fig"}F). No significant anticorrelated hits with increased transcript but decreased protein level in HSPCs were found, suggesting less pronounced effects of paused translation or protein degradation during hematopoietic commitment.

Extended Self-Protective Signature Highlights Posttranscriptional Regulation {#sec2.6}
----------------------------------------------------------------------------

To extend our findings to differentially expressed genes related to immune stress response, a protein-protein interaction analysis was carried out ([Figures 5](#fig5){ref-type="fig"} and [S5](#app2){ref-type="sec"}; [Table S7](#mmc8){ref-type="supplementary-material"}), integrating the GO biological process annotation of the 3,236 differentially expressed genes (^∗^ in [Figure 1](#fig1){ref-type="fig"}F) and our previously described proteome immune signature ([@bib24]). The resulting network covered a broad range of cellular compartments and gene classes including e.g., secreted inflammatory cytokines (*Cxcl2*, *Pf4*), plasma membrane receptors (*Cxcr1*, *Flt3*), and transcription regulators (*Mecom*, *Gata3*). Enrichment of self-protective processes in HSPCs highlighted by our proteome analysis (e.g., viral dsRNA sensors \[*Ddx58*, *Oas3*\]) was confirmed by the combined analysis on RNA and protein level ([Figure S5](#app2){ref-type="sec"}), indicating transcriptional shutdown of these programs upon commitment. Conversely, all detected genes involved in stress response to unfolded protein at the endoplasmic reticulum (*Calr*, *Hsp90b*) showed consistent suppression at RNA and protein level in HSPCs ([Figures 5](#fig5){ref-type="fig"} and [S5](#app2){ref-type="sec"}). In contrast, many proteins involved in mitochondrial response to oxidative stress (*Nqo1*, *Sod2*) showed strong anticorrelation with decreased RNA but increased protein levels, suggesting a coordinated regulation of translation in HSPCs and whereas *Tfrc*, a modulator of antibacterial cellular iron homeostasis was increased on both RNA and protein level in myeloid LS^−^K cells, its two ligands *Trf* and *Ltf* as well as iron transporter *Fth1* showed an anticorrelation. Finally, several factors involved in DNA repair (*Xrcc6*, *Xpc*) showed decreased RNA but increased protein expression in HSPCs, pointing to specific mechanisms leading to increased translation or protein stability ([Figure 5](#fig5){ref-type="fig"}). Taken together, by integrating transcriptome and proteome data, we achieved a global perspective on self-protective mechanisms in early hematopoiesis, which refines gene expression regulation to specific defense processes.

Energy Metabolism in HSPCs {#sec2.7}
--------------------------

Next, we characterized the regulation of gene expression in metabolic genes ([Figure 6](#fig6){ref-type="fig"}; [Table S8](#mmc9){ref-type="supplementary-material"}). Strikingly, more than half (seven out of 13) of the compared glycolytic enzymes showed anticorrelation between protein and RNA differences ([Figures 6](#fig6){ref-type="fig"}A and 6B). Whereas at the first step of glycolysis the mRNAs of all three hexokinases *Hk1-3* were lowly expressed in HSPCs, only Hk1 showed higher expression at the protein level. At the final step of glycolysis, the pyruvate kinases Pkm1 and Pkm2 were highly expressed on protein levels but lowly expressed on RNA levels ([Figures 6](#fig6){ref-type="fig"}A and 6B). Furthermore, several enzymes involved in intracellular glycogen breakdown (*Pgm1* and *Pgm2*) showed an anticorrelation between RNA and protein, which points to posttranscriptional regulation of this alternative entry into glycolysis. Although we did not detect significant changes for most enzymes involved in the TCA cycle, these transcripts showed higher mRNA levels in LS^−^K. In addition, our analysis revealed anticorrelation in a cluster of 46 enzymes that are likely to contribute to the energy-creating infrastructure of HSPCs (e.g., galactose \[*Glb1*/Bgal\], superoxide/NADPH \[*Prdx6*\], and acetyl CoA fatty acid \[*Acads*\] metabolism). In summary, whereas parts of energy metabolism are consistently regulated both at mRNA and protein level, many enzymes show anticorrelation pointing to posttranscriptional regulation in HSPCs and LS^−^K.

Discussion {#sec3}
==========

In this study, we integrated transcriptome and proteome data and characterized the inventory of HSPCs and their immediate myeloid committed progeny (LS^−^K) ([Figure S6](#app2){ref-type="sec"}). With almost 20,000 identified expressed genes including more than 3,000 significantly regulated ones, these data represent a deep analysis comparing these two cell populations that can be accessed as an interactive online resource (<http://vega.embl.de/LSK>).

The specific cell adhesion repertoire exclusively detected in HSPCs strongly supports the concept of a distinct autonomous microenvironment of HSPCs in the bone marrow ([@bib18; @bib58]), which probably serves important protective functions, among others. In line with this notion, secreted kallikrein-related proteases exert pleiotropic roles in a broad range of physiological processes including inflammatory response ([@bib44]) and thus might contribute to HSPC specific defense signaling via proteolytic events e.g., via TGF-beta- or Protease-activated receptor (PAR)-GPCR signaling. The immune response network presented in this study significantly extends our knowledge of distinct self-protective mechanisms elevated in HSPCs already at steady state and is in agreement with the recently observed reversible activation of HSCs under conditions of stress ([@bib11; @bib52]).

Maintenance of HSC quiescence under homeostatic conditions is tightly linked to mitochondrial oxidative response ([@bib48; @bib64]). In particular, response to oxidative stress is known to be regulated by a variety of mechanisms including targeting of RNA-binding proteins, RNA half-life, and translation efficiency ([@bib56]). The comparison of the transcriptome and proteome data sets demonstrates an anticorrelation for central superoxide enzymes like *Gpx1* and *Sod2* and provides evidence for posttranscriptional regulation of ROS response and other defense mechanisms like iron metabolism in early hematopoiesis. Notably, expression of iron-response proteins (IRPs) like FTH1 or ACO2 is tightly regulated via iron-responsive elements (IREs) ([@bib19]). In addition, the expression of regulatory hormone Hepcidin, which is crucial for cellular iron homeostasis, has been shown to be strongly dependent on Bmp---(Hemojuvelin \[HJV\])-Smad signaling ([@bib6]). Thus, the BMP-Smad signaling axis, of which we found its components to be highly expressed in HSPCs, might as well be involved in the regulation of iron homeostasis in multipotent cells.

Although most differentially expressed genes showed consistent expression on RNA and protein level and therefore may not require posttranscriptional regulation, our correlation analysis uncovered isozyme specific regulation for essential glycolytic enzymes (hexokinases, pyruvate kinases) on either RNA or protein level, which argues for blocked translation or increased protein turnover. The higher transcript levels of TCA cycle enzymes potentially boost oxidative phosphorylation after commitment. Notably, our findings highlight additional regulation of carboxylic acid metabolism, which allows novel perspectives on the coordination of metabolism along early hematopoiesis and suggests that energy metabolism as well as the response to immune mediated stress are modulated by different gene-regulatory mechanisms affecting differential and process-specific transcription, translation, mRNA, or protein turnover. The immune response signature described here at steady state should be complemented by a global analysis of induced stress response of HSPCs.

Our study identifies TFs and lncRNAs as candidates controlling multipotency and/or commitment. Indeed, loss of TFs including Foxo3a, one of the differentially abundant genes in our study, has been demonstrated to severely affect HSPC integrity in functional KO mouse studies ([@bib40]). Because some lncRNAs are known to facilitate expression of transcriptional regulators during development ([@bib36]), the differentially expressed lncRNAs identified might exert similar roles in HSPCs, leading to stabilization of multipotency. *Malat1*, which is upregulated in several human tumors and plays an important role in extravasation in lung cancer metastasis ([@bib17]), might be involved in promoting stem cell motility and HSC-niche interactions in the bone marrow. In addition, because the vast majority of differentially expressed lncRNAs lack molecular and biological characterization, they are now attractive candidates for further exploration in vivo. In summary, in this study we provide the global landscape gene expression of protein-coding and noncoding transcripts during early hematopoiesis. It represents a comprehensive resource for the stem cell field and will serve as a valuable resource for functional exploration of self-renewal, multipotency, and lineage determination.

Experimental Procedures {#sec4}
=======================

Animals {#sec4.1}
-------

Eight- to 12-week-old female C57BL/6 mice purchased from Harlan Laboratories were used throughout the study. All mice were maintained in the animal facility at DKFZ, under specific pathogen-free (SPF) conditions and kept in individually ventilated cages (IVCs). Animal procedures were performed according to protocols approved by the German authorities, Regierungspräsidium Karlsruhe (Nr. Z110/02, DKFZ \#261).

FACS Staining, Sorting, and Cell-Cycle Analysis {#sec4.2}
-----------------------------------------------

Bone marrow was isolated from hind legs (femur, tibia), hips (ilium), and backbone (vertebra). Muscle, connective tissue, and spinal cord were removed; bones were crushed in RPMI/2% FBS (GIBCO) using mortar and pestle. Single-cell suspensions were made by flushing through a 40 μm filter mesh. Cell numbers and viability were determined using a ViCell Counter (Beckman Coulter). To deplete lineage-positive cells, total bone marrow was stained 30 min with a combination of monoclonal rat antibodies directed against mature cell specific lineage markers (for detailed specifications, see [Supplemental Experimental Procedures](#app2){ref-type="sec"}). Labeled cells were incubated for 20 min with polyclonal sheep anti-rat immunoglobulin-G-coated magnetic Dynabeads (Invitrogen) at a ratio 2:1 beads to cell and depleted using a magnet, enriching for the lineage-negative (Lin^neg^) cell fraction. Beads were washed twice with RPMI/2% FBS to harvest residual cell fractions. Centrifugation steps were carried out at 1,500 rpm and 4°C for 5 min (5810r, Eppendorf). To specify multipotent and myeloid progenitor fractions, as well as refined HSC and MPP populations, the Lin^neg^ fraction was stained 30 min using rat monoclonal fluorochrome-coupled antibodies (see [Supplemental Experimental Procedures](#app2){ref-type="sec"}). All antibodies were titrated prior to use. Cell sorting was performed on a FACS Aria I or II (Becton Dickinson) at the DKFZ Flow Cytometry Service Unit, using the following sort parameters: 70 μm nozzle; 15,000 evt/s; 70 psi. LS^+^K cells and LS^−^K cells were obtained by sorting Lin^neg^SCA-1^+^c-KIT^+^ and Lin^neg^SCA-1^+^c-KIT^−^, respectively, in biological triplicate ([Figures S1](#app2){ref-type="sec"}A and S1B). Sorted cells were collected into ice-cold RNA lysis buffer (ARCTURUS PicoPure RNA Isolation Kit \[Life Technologies, Invitrogen\]) and stored at −80°C until further usage. Of note, to determine sample's purity we resorted a fraction of each population ([Figure S1](#app2){ref-type="sec"}B; purity greater than 95%). Cell-cycle analysis together with six-color surface staining to define myeloid subsets was performed as previously described ([@bib59]) using Ki67-FITC (BD Biosciences) and Hoechst 33342 (Molecular Probes).

Total RNA Isolation and RNA-Seq {#sec4.3}
-------------------------------

Total RNA isolation was performed from the indicated populations using ARCTURUS PicoPure RNA Isolation Kit (Life Technologies, Invitrogen) according to the manufacturer's instructions. DNase treatment was performed using RNase-free DNase Set (QIAGEN). Total RNA was used for quality controls and for normalization of starting material ([Figure S2](#app2){ref-type="sec"}). cDNA-libraries were generated with 10 ng of total RNA using the SMARTer Ultra Low RNA Kit for Illumina Sequencing (Clontech) according to the manufacturer's indications. Of note, 12 cycles were used for the amplification of cDNA, respectively. Paired-end adaptors were applied to each population. Sequencing was performed with the HiSeq2000 device (Illumina) and one sample per lane. Quality controls before and after sequencing and schematic overview of sampling workflow are shown in [Figures S1](#app2){ref-type="sec"} and [S2](#app2){ref-type="sec"}.

Processing of RNA-Seq Data {#sec4.4}
--------------------------

RNA-seq reads were aligned to the reference genome of *Mus musculus* GRcm38 from ENSEMBL release 69 ([@bib12]) using GSNAP version 2012-07-20. The alignment quality statistics were computed using scripts based on the HTSeq Python library ([@bib5]) and R/Bioconductor ([@bib14]). The results from these statistics are available in [Figure S2](#app2){ref-type="sec"}. Only uniquely aligned reads unambiguously assigned to annotated exons were considered for differential expression analysis. The differential expression analysis was done using DESeq ([@bib3]), and the differential exon usage analysis (<http://www-huber.embl.de/DEULSK/testForDEU.html>) was done using DEXSeq ([@bib4]). In RNA-seq count data, the power to detect differentially expressed genes varies widely through the dynamic range. Therefore, to avoid associated biases in gene set enrichment analysis, we generated background set of genes whose expression distribution approximated the expression distribution of our set of differentially expressed genes ([@bib20]). Genes were called as quantified genes if they had at least 20 read counts per cell type. We tested differentially expressed genes from the RNA-seq data for overrepresented GO categories using Fisher's exact test. The R/Bioconductor scripts used for this study are available as an online resource (<http://www-huber.embl.de/DEULSK/supplementary_file.pdf>).

Gene Expression Analysis by Real-Time PCR {#sec4.5}
-----------------------------------------

For real-time PCR, total RNA was isolated as described above and reverse-transcribed using Superscript III reverse transcriptase (Life Technologies, Invitrogen). The PCR was performed using the Fast SYBR Green Master Mix (Applied Biosystems) on a ViiA 7 Real-Time PCR System (Applied Biosystems) according to the manufacturer's instructions. Primers were designed using the Universal Probe Library Assay Design Center (Roche). For primers used, see [Supplemental Experimental Procedures](#app2){ref-type="sec"}. The analysis of amplification curves was carried out using the ViAA 7 Software v1.1 (Applied Biosystems).

Bioinformatic Analysis {#sec4.6}
----------------------

For Integration of transcriptomics and proteomics, the ENSEMBL identifiers were associated to their respective UniProt identifiers using BioMart ([@bib10]). For the purpose of this analysis, RNAs and proteins were considered differentially expressed if the adjusted p value \<0.1. We tested for GO enriched categories using Fishers' exact test, the functional annotation tool of MetaCore (GeneGo; [@bib33]), protein classification by Panther ([@bib30]), and the BiNGO plugin ([@bib28]) for Cytoscape ([@bib43]). To investigate interactions between differentially expressed proteins, networks were constructed using STRING ([@bib47]). Interaction networks were visualized using Cytoscape; nodes were arranged after manual curation according to Gene Ontology (UniProt; ([@bib21]), extensive literature search, and STRING interaction scores. To identify possible transcription factor targets, the Transcription Factor Encyclopedia ([@bib65]) was used as a resource.
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====================
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Accession Numbers {#app1}
=================

The RNA-seq data sets from LS^+^K and LS^−^K cells can be accessed through ArrayExpress (<https://www.ebi.ac.uk/arrayexpress>; accession number E-MTAB-1963). An interactive online resource that also integrates the previous proteome data ([@bib24]) can be found under the following link: <http://vega.embl.de/LSK>.

Supplemental Information {#app2}
========================

Supplemental Information includes Supplemental Experimental Procedures, six figures, and eight tables and can be found with this article online at [http://dx.doi.org/10.1016/j.stemcr.2014.08.012](10.1016/j.stemcr.2014.08.012){#intref0040}.

Supplemental Information {#app3}
========================

Document S1. Supplemental Experimental Procedures and Figures S1--S6Table S1. RNA-Seq Data of LS^+^K and LS^−^K CellsRNA-seq data for all 37,315 genes. These include 3,236 genes with differential expression between LS^+^K and LS^−^K cells (FDR = 0.05).Table S2. GO Term Enrichment in Differentially Expressed GenesAll GO terms with p adj. value \<0.05 and GO term listed in Figure 1F are separated in different sheets.Table S3. Differentially Expressed Genes Involved in Transcriptional ControlOne hundred seventy-seven differentially expressed genes between LS^+^K and LS^−^K involved in transcriptional control (FDR=0.05). Molecular functions according to GeneGo and Panther are annotated. See also Figure 3A.Table S4. Annotation of De Novo/Putative Long Noncoding RNAsAnnotation file containing the filtered assemblies from Cufflinks in General Transfer Format (GTF) format. The initial assemblies from Cufflinks were filtered based on (1) their length (\>200 bp), (2) proximity to annotated genes (\>10 Mb), (3) coverage (\>20 mean fragment counts across all the samples), and (4) lack of coding sequences (\<100 consecutive codons). Additionally, we only considered multiexonic assemblies. A total of 713 potential de novo predicted long noncoding RNAs and 149 differentially expressed de novo predicted long noncoding RNAs (FDR = 0.05).Table S5. Differential Splicing AnalysisTwo hundred fourteen differentially spliced events (FDR = 0.1) found using MISO are listed.Table S6. Correlation of RNA and Protein Expression ChangesRNA-seq and proteomics (Klimmeck et al., 2012) data for the 4,919 mapped quantified proteins. For this analysis, differentially expressed hits with FDR = 0.1 were considered.Table S7. Differentially Expressed Genes Involved in Immune ResponseSix hundred forty differentially expressed hits (FDR = 0.05) related to immune response. See also Figures 5 and S5.Table S8. Differentially Expressed Genes Involved in Energy MetabolismOne hundred thirty-one differentially expressed genes and proteins (FDR = 0.05). See also Figure 6.Document S2. Article plus Supplemental Information
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![Quantitative Transcriptomic Analysis of Hematopoietic Stem and Progenitor Cells\
(A) Early hematopoiesis. Multipotent hematopoietic stem cells (HSCs) give rise to multipotent progenitors (MPPs), which commit either to myeloid specified progenitors (CMPs, common myeloid progenitors; GMP, granulocyte-macrophage progenitor; MEP, megakaryocyte/erythrocyte progenitor) or to lymphoid specified progenitors.\
(B) Experimental design. Cell fractions were purified with fluorescence-activated cell sorting (FACS) using specific surface markers for Lineage (Lin), SCA-1, and c-KIT, which distinguish multipotent stem progenitor cells (LS^+^K) from myeloid committed (LS^−^K) cells. For analysis of posttranscriptional regulation, the transcriptome was integrated with our previously published proteome ([@bib24]) (asterisk).\
(C) Clustering of biological replicates. Heatmap represents similarity of samples from black (highest) to light gray (smallest).\
(D) Classification of the quantified genes by RNA categories. The pie chart legend indicates percentage and absolute number of genes for each type of RNA. LncRNA, long noncoding RNA; snoRNA, small nucleolar RNA; miRNA, microRNA; IG_V gene, immunoglobin V gene; snRNA, small nuclear RNA; miscRNA, miscellaneousRNA; rRNA, ribosomal RNA; IG_J gene, immunoglobulin J gene; IG_C gene, immunoglobulin C gene; Mt_tRNA, mitochondrial transfer RNA; TR_V gene, V gene. Genes were called as quantified genes if they had at least 20 read counts per cell type.\
(E) Differential gene expression between multipotent and myeloid committed progenitors. The plot shows for each gene (indicated by dots) a measure of its average expression (x axis) versus the logarithm of the ratio between expression levels in LS^+^K and LS^−^K. Red and blue coloring of dots represents differentially expressed genes (FDR = 0.05). Red dots represent upregulated genes in LS^+^K (1,970 genes). Blue dots depict upregulated genes in LS^−^K (1,266). The five most abundant genes in each fraction are shown in italics.\
(F) Biological processes enriched in the annotation of differentially expressed genes. Within each gene ontology (GO) term, the number of genes with higher expression in LS^+^K (red) and LS^−^K (blue) are indicated. Processes related to ^∗^immune response; ^∗∗^cell adhesion; ^∗∗∗^transcriptional control, ^∗∗∗∗^metabolism, or ^∗∗∗∗∗^cell cycle are labeled. The odd ratios are calculated with respect to background. For complete list of differential GO terms, see [Table S2](#mmc3){ref-type="supplementary-material"}.](gr1){#fig1}

![Cell-Cycle Stages of HSPCs and Myeloid Committed Precursors\
(A) Protein-protein interaction analysis built based on GO terms related to cell cycle. Genes highly expressed in LS^+^K cells are shown in red, and genes higher in LS^−^K cells are shown in blue. Log2 fold change is represented.\
(B) Heatmap of cell-cycle regulators. mRNA expression levels in LS^+^K, LS^−^K, CMPs, GMPs, and MEPs based on real-time PCR. *Z* scores were calculated per row to highlight expression differences per gene between populations. See [Figures S4](#app2){ref-type="sec"}A and S4B.\
(C and D) FACS analysis of cell-cycle stages of HSPCs and myeloid progenitors. (C) Shows representative gating scheme. (D) Quantification of three biological replicates. Error bars indicate ±SD of three independent biological replicates.](gr2){#fig2}

![Differential Expression of Genes Involved in Transcriptional Control and Landscape of lncRNA in Multipotent and Myeloid Committed Progenitors\
(A) Protein-protein interaction analysis built based on GO-terms related to transcriptional control. Each gene was functionally classified according to GeneGo MetaCore annotation and manual curation. Genes highly expressed in LS^+^K cells are shown in red, and genes higher expressed in LS^−^K cells are shown in blue. The color bar indicates the color code for Log2 fold change. For the complete list of differentially expressed genes involved in transcriptional control, see [Table S3](#mmc4){ref-type="supplementary-material"}.\
(B--E) Differential landscape of lncRNAs in multipotent and myeloid committed progenitors.\
(B) Differentially abundant lncRNAs. Of the 67 lncRNAs with significant change in abundance, the table shows ten examples with changes in each direction. For the complete list, see [Table S1](#mmc2){ref-type="supplementary-material"}. Inf, infinite number, meaning read count of one population is zero.\
(C) Top abundant lncRNAs. Ten examples for highly abundant lncRNAs sorted by mean counts.\
(D) Confirmation of differentially expressed lncRNAs by real-time PCR. mRNA expression levels of lncRNAs *Meg3* and *Malat1* in LS^+^K (red) and LS^−^K (blue) samples were quantified by real-time PCR. Numbers represent Log2 fold changes from real-time PCR (left, bold) and RNA-seq (right) data for LS^+^K compared to LS^−^K. For all real-time PCR data, mean values means ± SD of three independent biological replicates with three technical replicates each are shown.\
(E) Expression analysis of lncRNA *Malat1* in HSCs and MPPs. mRNA expression levels of *Malat1* in HSC, MPP1, MPP2, MPP3, MPP4 ([@bib60]), and LS^−^K cells were analyzed by real-time PCR.\
(F) Expression analysis of lncRNA *1700006J14Rik* in myeloid committed precursors. RNA expression levels LS^+^K, LS^−^K, CMPs, GMPs, and MEPs based on real-time PCR. ^∗^p \< 0.05; ^∗∗^p \< 0.01; ^∗∗∗^p \< 0.001; ^∗∗∗∗^p \< 0.001 (two-sided Student's t test).](gr3){#fig3}

![Gene Expression Regulation in Multipotency and Commitment\
(A and B) Analysis of transcript isoform regulation.\
(A) Differential exon usage in genes involved in transcriptional control. Forty-eight out of 177 genes exhibited exon usage changes between LS^+^K and LS^−^K cells in one to 12 exons (top 30 genes in alphabetical order are shown; for full annotation, see [Table S3](#mmc4){ref-type="supplementary-material"}).\
(B) Example: TF (*Mdfi*) shows differential exon usage. The data are consistent with higher levels of isoform \#6 of *Mdfi* in LS^+^K (red) compared to LS^−^K (blue).\
(C--F) Analysis of posttranscriptional regulation. (C) Overview of integration of transcriptome and proteome data. Transcriptome RNA-seq data (19,824 genes quantified), and proteome data (5,027 proteins quantified) were mapped to each other based on Uniprot IDs using BioMart. Ninety-eight percent of quantified proteins could be mapped (4,919 out of 5,027 total). (D) Overall correlation. Correlation of RNA to protein expression ratios (Log2 fold change) for all 4,919 genes. Four hundred nineteen hits were significant on both RNA and protein level (FDR = 0.1), shown in red. R, Pearson correlation coefficient. (E) Correlation of 419 hits significant on RNA and protein level (FDR = 0.1). (F) GO enrichment analysis of 419 hits significant on RNA and protein level (FDR = 0.1). GO enrichment analysis was carried out on 342 hits, which were consistently up- or downregulated (yellow), and 77 hits, which were anticorrelated with increased protein but decreased RNA ratios (pink).](gr4){#fig4}

![Gene Expression Regulation of Self-Protective Immune Response in Multipotency and Commitment\
Protein-protein interaction visualization of significantly overrepresented GO processes related to immune response (see ^∗^ in [Figure 1](#fig1){ref-type="fig"}F). For full list of involved differentially expressed genes, see [Table S7](#mmc8){ref-type="supplementary-material"}. For high-resolution image of the interaction network, see [Figure S5](#app2){ref-type="sec"}. Protein expression ratios were integrated for 138 out of 480 nodes total. Expression levels are displayed in color code (red, enriched in multipotent LS^+^K; blue, enriched in LS^−^K).](gr5){#fig5}

![Gene Expression Regulation of Energy Metabolism\
Protein-protein interaction analysis of significantly overrepresented GO processes related to metabolism (^∗∗∗∗^ in [Figure 1](#fig1){ref-type="fig"}F). This network was imposed on a pathway map based on GeneGo pathway maps of glycolysis and gluconeogenesis. Expression levels are displayed in color code (red, enriched in multipotent LS^+^K; blue, enriched in LS^−^K). For full list of involved differential hits, see [Table S8](#mmc9){ref-type="supplementary-material"}.\
(A) Protein expression levels.\
(B) Gene expression levels. Genes with p adj \<0.1 for both RNA and protein are shown with yellow (consistent changes) or pink boxes (anticorrelating changes). Gray squares indicate quantification in less than three replicates.](gr6){#fig6}

###### 

List of 77 Anticorrelating Hits between RNA and Protein Level

  Uniprot ID   Ensembl Transcript ID   Gene Name         Protein Name                                                              RNA-seq Log2 Fold Change LS^+^K/LS^−^K   RNA-seq adj. p Value   Proteome Log2 Fold Change LS^+^K/LS^−^K   Proteome adj. p Value   Differential Exon Usage
  ------------ ----------------------- ----------------- ------------------------------------------------------------------------- ---------------------------------------- ---------------------- ----------------------------------------- ----------------------- -------------------------
  Q8BHA3       ENSMUSG00000020956      *6530401N04Rik*   D-tyrosyl-tRNA(Tyr) deacylase 2                                           −0.70                                    0.0692                 0.65                                      0.0901                  no
  Q07417       ENSMUSG00000029545      *Acads*           acyl-coenzyme A dehydrogenase, short chain, isoform CRA_a                 −0.79                                    0.0350                 0.53                                      0.0035                  no
  P28271       ENSMUSG00000028405      *Aco1*            aconitase 1                                                               −0.98                                    0.0041                 0.39                                      0.0599                  no
  Q99KI0       ENSMUSG00000022477      *Aco2*            aconitate hydratase, mitochondrial                                        −0.93                                    0.0058                 0.26                                      0.0362                  yes
  Q9Z2N8       ENSMUSG00000027671      *Actl6a*          actin-like protein 6A;23 kDa protein                                      −0.75                                    0.0364                 0.28                                      0.0888                  no
  P54822       ENSMUSG00000022407      *Adsl*            adenylosuccinate lyase                                                    −0.68                                    0.0630                 0.25                                      0.0350                  no
  Q9ESW4       ENSMUSG00000029916      *Agk*             acylglycerol kinase, mitochondrial                                        −0.71                                    0.0597                 0.45                                      0.0270                  yes
  P50247       ENSMUSG00000048087      *Ahcy*            adenosylhomocysteinase                                                    −1.20                                    0.0004                 0.43                                      0.0050                  no
  Q9JII6       ENSMUSG00000028692      *Akr1a1*          alcohol dehydrogenase \[NADP^+^\]                                         −0.88                                    0.0101                 0.39                                      0.0423                  yes
  Q9JLJ2       ENSMUSG00000026687      *Aldh9a1*         aldehyde dehydrogenase 9A1                                                −1.05                                    0.0015                 0.20                                      0.0548                  no
  P28352       ENSMUSG00000035960      *Apex1*           DNA-(apurinic or apyrimidinic site) lyase                                 −0.64                                    0.0997                 0.67                                      0.0290                  no
  Q564P4       ENSMUSG00000006589      *Aprt*            adenine phosphoribosyltransferase                                         −0.85                                    0.0137                 0.55                                      0.0871                  no
  P84078       ENSMUSG00000048076      *Arf1*            ADP-ribosylation factor 1                                                 −1.02                                    0.0020                 0.28                                      0.0798                  yes
  Q99PT1       ENSMUSG00000025132      *Arhgdia*         Rho GDP-dissociation inhibitor 1                                          −0.73                                    0.0391                 0.18                                      0.0737                  yes
  P47754       ENSMUSG00000015733      *Capza2*          F-actin-capping protein subunit alpha-2                                   −0.69                                    0.0915                 0.30                                      0.0708                  yes
  Q32P00       ENSMUSG00000057886      *Cbx3*            chromobox homolog 3                                                       −0.81                                    0.0654                 0.35                                      0.0082                  no
  Q91WS0       ENSMUSG00000037710      *Cisd1*           CDGSH iron sulfur domain-containing protein 1                             −0.63                                    0.0942                 0.43                                      0.0235                  no
  P61202       ENSMUSG00000027206      *Cops2*           COP9 signalosome complex subunit 2                                        −0.77                                    0.0316                 0.28                                      0.0484                  no
  Q8C243       ENSMUSG00000007891      *Ctsd*            cathepsin D                                                               −0.63                                    0.0903                 0.27                                      0.0281                  yes
  Q91VR5       ENSMUSG00000037149      *Ddx1*            ATP-dependent RNA helicase DDX1                                           −0.87                                    0.0115                 0.22                                      0.0858                  yes
  Q9ESX5       ENSMUSG00000031403      *Dkc1*            dyskeratosis congenita 1                                                  −0.71                                    0.0492                 0.27                                      0.0288                  yes
  P17182       ENSMUSG00000059040      *Eno1*            alpha-enolase                                                             −1.04                                    0.0106                 0.18                                      0.0798                  no
  Q921G7       ENSMUSG00000027809      *Etfdh*           electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial   −0.77                                    0.0325                 0.39                                      0.0206                  no
  Q78JE5       ENSMUSG00000032309      *Fbxo22*          F-box only protein 22                                                     −0.73                                    0.0494                 0.46                                      0.0539                  no
  P23780       ENSMUSG00000045594      *Glb1*            β-galactosidase                                                           −0.69                                    0.0633                 0.51                                      0.0447                  no
  Q9CPU0       ENSMUSG00000024026      *Glo1*            lactoylglutathione lyase                                                  −0.74                                    0.0424                 0.80                                      0.0101                  no
  Q3UJH8       ENSMUSG00000025190      *Got1*            aspartate aminotransferase 1                                              −0.73                                    0.0524                 0.52                                      0.0167                  no
  P11352       ENSMUSG00000063856      *Gpx1*            glutathione peroxidase 1                                                  −1.09                                    0.0216                 0.37                                      0.0167                  no
  P51859       ENSMUSG00000004897      *Hdgf*            hepatoma-derived growth factor                                            −0.67                                    0.0684                 0.27                                      0.0334                  yes
  Q9ERZ0       ENSMUSG00000028332      *Hemgn*           hemogen                                                                   −1.06                                    0.0580                 1.01                                      0.0582                  no
  Q3UE51       ENSMUSG00000037012      *Hk1*             hexokinase 1                                                              −0.69                                    0.0520                 1.03                                      0.0004                  yes
  P17095       ENSMUSG00000046711      *Hmga1*           high mobility group protein A1                                            −1.36                                    0.0000                 1.12                                      0.0562                  yes
  O54879       ENSMUSG00000015217      *Hmgb3*           high mobility group protein B3                                            −0.83                                    0.0171                 0.42                                      0.0202                  no
  B2M1R6       ENSMUSG00000021546      *Hnrnpk*          heterogeneous nuclear ribonucleoprotein K                                 −0.81                                    0.0185                 0.23                                      0.0494                  yes
  Q9D0E1       ENSMUSG00000059208      *Hnrnpm*          heterogeneous nuclear ribonucleoprotein M                                 −0.79                                    0.0235                 0.19                                      0.0809                  yes
  Q3TME6       ENSMUSG00000027531      *Impa1*           inositol (myo)-1(or 4)-monophosphatase 1                                  −0.86                                    0.0124                 0.65                                      0.0059                  no
  P62482       ENSMUSG00000028931      *Kcnab2*          voltage-gated potassium channel subunit beta-2                            −0.68                                    0.0602                 0.36                                      0.0782                  yes
  Q9CPY7       ENSMUSG00000039682      *Lap3*            cytosol aminopeptidase                                                    −0.80                                    0.0225                 0.24                                      0.0495                  yes
  P48678       ENSMUSG00000028063      *Lmna*            ILamin-A/C                                                                −1.52                                    0.0051                 1.19                                      0.0106                  no
  P97823       ENSMUSG00000025903      *Lypla1*          acyl-protein thioesterase 1                                               −0.84                                    0.0152                 0.48                                      0.0220                  yes
  Q9CRB2       ENSMUSG00000001056      *Nhp2*            H/ACA ribonucleoprotein complex subunit 2                                 −0.79                                    0.0615                 0.29                                      0.0862                  no
  Q9D0T1       ENSMUSG00000063543      *Nhp2l1*          NHP2-like protein 1                                                       −1.01                                    0.0181                 0.31                                      0.0283                  no
  Q64669       ENSMUSG00000003849      *Nqo1*            NAD(P)H dehydrogenase \[quinone\] 1                                       −1.05                                    0.0302                 1.02                                      0.0430                  no
  Q63850       ENSMUSG00000043858      *Nup62*           nuclear pore glycoprotein p62                                             −0.88                                    0.0100                 0.36                                      0.0560                  no
  Q8K183       ENSMUSG00000032788      *Pdxk*            pyridoxal kinase                                                          −0.73                                    0.0432                 0.50                                      0.0141                  yes
  P70296       ENSMUSG00000032959      *Pebp1*           phosphatidylethanolamine-binding protein 1                                −0.76                                    0.0321                 0.57                                      0.0027                  no
  Q5SUR0       ENSMUSG00000020899      *Pfas*            phosphoribosylformylglycinamidine synthase                                −0.79                                    0.0240                 0.19                                      0.0780                  yes
  Q9D0F9       ENSMUSG00000029171      *Pgm1*            phosphoglucomutase-1                                                      −1.11                                    0.0007                 0.89                                      0.0005                  yes
  Q7TSV4       ENSMUSG00000029171      *Pgm2*            phosphoglucomutase-2                                                      −1.11                                    0.0007                 0.64                                      0.0095                  yes
  P52480       ENSMUSG00000032294      *Pkm*             isoform M2 of Pyruvate kinase isozymes M1/M2                              −0.76                                    0.0340                 0.30                                      0.0317                  yes
  P52480       ENSMUSG00000032294      *Pkm*             isoform M1 of Pyruvate kinase isozymes M1/M2                              −0.76                                    0.0340                 1.27                                      0.0447                  yes
  P62137       ENSMUSG00000040385      *Ppp1ca*          serine/threonine-protein phosphatase PP1-alpha                            −0.78                                    0.0263                 0.18                                      0.0886                  no
  P58389       ENSMUSG00000039515      *Ppp2r4*          serine/threonine-protein phosphatase 2A regulatory subunit B              −0.71                                    0.0482                 0.36                                      0.0218                  yes
  Q6A0D0       ENSMUSG00000026701      *Prdx6*           peroxiredoxin-6                                                           −1.05                                    0.0012                 0.55                                      0.0050                  yes
  Q3U5I2       ENSMUSG00000006498      *Ptbp1*           polypyrimidine tract binding protein 1                                    −1.02                                    0.0019                 0.26                                      0.0338                  yes
  Q8BVI4       ENSMUSG00000015806      *Qdpr*            dihydropteridine reductase                                                −0.63                                    0.0973                 0.34                                      0.0087                  no
  Q8C2Q3       ENSMUSG00000006456      *Rbm14*           RNA-binding protein 14                                                    −0.82                                    0.0264                 0.64                                      0.0081                  yes
  Q9R1T2       ENSMUSG00000052833      *Sae1*            SUMO-activating enzyme subunit 1                                          −0.74                                    0.0381                 0.18                                      0.0875                  yes
  Q9D154       ENSMUSG00000044734      *Serpinb1a*       leukocyte elastase inhibitor A                                            −0.69                                    0.0601                 1.56                                      0.0029                  no
  Q9JJU8       ENSMUSG00000031246      *Sh3bgrl*         SH3 domain-binding glutamic acid-rich-like protein                        −0.71                                    0.0494                 0.27                                      0.0616                  no
  O55242       ENSMUSG00000036078      *Sigmar1*         sigma 1-type opioid receptor                                              −0.68                                    0.0663                 0.34                                      0.0421                  no
  Q8BH59       ENSMUSG00000027010      *Slc25a12*        calcium-binding mitochondrial carrier protein Aralar1                     −1.01                                    0.0027                 0.72                                      0.0082                  yes
  Q9QXX4       ENSMUSG00000015112      *Slc25a13*        calcium-binding mitochondrial carrier protein Aralar2                     −0.79                                    0.0334                 0.42                                      0.0360                  no
  P09671       ENSMUSG00000006818      *Sod2*            superoxide dismutase \[Mn\], mitochondrial                                −0.81                                    0.0203                 0.60                                      0.0068                  no
  Q64442       ENSMUSG00000027227      *Sord*            sorbitol dehydrogenase                                                    −0.68                                    0.0629                 0.63                                      0.0108                  yes
  Q64105       ENSMUSG00000033735      *Spr*             sepiapterin reductase                                                     −0.67                                    0.0762                 0.87                                      0.0068                  yes
  Q9WUM5       ENSMUSG00000052738      *Suclg1*          succinyl-CoA ligase \[GDP-forming\] subunit alpha, mitochondrial          −0.64                                    0.0855                 0.33                                      0.0109                  no
  Q9Z2I8       ENSMUSG00000061838      *Suclg2*          succinyl-CoA ligase \[GDP-forming\] subunit beta, mitochondrial           −0.69                                    0.0617                 0.57                                      0.0140                  no
  Q93092       ENSMUSG00000025503      *Taldo1*          transaldolase                                                             −0.74                                    0.0386                 0.20                                      0.0583                  no
  P10711       ENSMUSG00000033813      *Tcea1*           transcription elongation factor A protein 1                               −0.74                                    0.0423                 0.26                                      0.0562                  yes
  P17751       ENSMUSG00000023456      *Tpi1*            triosephosphate isomerase 1                                               −0.90                                    0.0078                 0.86                                      0.0008                  no
  Q9QZE7       ENSMUSG00000056820      *Tsnax*           translin-associated protein X                                             −0.74                                    0.0408                 0.76                                      0.0539                  no
  Q64727       ENSMUSG00000021823      *Vcl*             vinculin                                                                  −0.90                                    0.0178                 0.28                                      0.0548                  no
  Q60932       ENSMUSG00000020402      *Vdac1*           voltage-dependent anion-selective channel protein 1                       −1.00                                    0.0023                 0.23                                      0.0698                  no
  P32921       ENSMUSG00000021266      *Wars*            tryptophanyl-tRNA synthetase, cytoplasmic                                 −0.66                                    0.0708                 0.31                                      0.0430                  yes
  Q923D5       ENSMUSG00000030216      *Wbp11*           WW domain-binding protein 11                                              −0.81                                    0.0203                 0.21                                      0.0895                  no
  P62259       ENSMUSG00000020849      *Ywhae*           14-3-3 protein epsilon                                                    −0.79                                    0.0238                 0.34                                      0.0086                  no

FDR = 0.1 for RNA and protein.
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